Home » FDA Approves Novartis’ Meningitis Vaccine in Children
FDA Approves Novartis’ Meningitis Vaccine in Children
Novartis announced Monday that it received approval from the US Food and Drug Administration for the use of Menveo (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in individuals 2 to 10 years of age.
myScience
myScience
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May